World's Best Scientists 2026 revealed!
Herbert L. Bonkovsky

Herbert L. Bonkovsky

D-Index & Metrics

Medicine

D-Index
104
Citations
39063
World Ranking
7064
National Ranking
3713

Overview

Herbert L. Bonkovsky is affiliated with Wake Forest University in the United States. Their research spans several interconnected domains within medicine and biochemistry, with an emphasis on molecular biology and hepatology.

The scientist has contributed extensively to fields including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broad areas, their work further concentrates on subfields such as:

  • Molecular Biology
  • Pharmacology
  • Pediatrics, Perinatology and Child Health
  • Hepatology
  • Rheumatology

The primary research topics addressed by Bonkovsky involve:

  • Porphyrin Metabolism and Disorders
  • Heme Oxygenase-1 and Carbon Monoxide
  • Drug-Induced Hepatotoxicity and Protection
  • Neonatal Health and Biochemistry
  • Folate and B Vitamins Research
  • Liver Disease Diagnosis and Treatment
  • Metabolism and Genetic Disorders

Frequent collaborators in their research include:

  • Robert J. Fontana
  • Karl E. Anderson
  • Manisha Balwani
  • Huiman X. Barnhart
  • D. Montgomery Bissell

Bonkovsky's work has been published in several venues, notably:

  • UNC Libraries
  • The American Journal of Gastroenterology
  • Gastroenterology
  • Journal of Hepatology
  • Liver International

Recent publications authored or coauthored by Bonkovsky include:

  • Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria, 2020, New England Journal of Medicine
  • United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts, 2020, Toxicology Reports
  • HLA-B*35:01 and Green Tea-Induced Liver Injury, 2020, Hepatology
  • Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN], 2022, The American Journal of Medicine
  • Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study, 2021, Liver International

Best Publications

  • A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

    Ludmila Prokunina-Olsson;Brian Muchmore;Wei Tang;Ruth M Pfeiffer

  • Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

    Naga Chalasani;Robert J. Fontana;Herbert L. Bonkovsky;Herbert L. Bonkovsky;Herbert L. Bonkovsky;Paul B. Watkins

  • ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

    Naga P. Chalasani;Paul Hideyo Hayashi;Herbert L. Bonkovsky;Victor J. Navarro

  • Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study

    Naga Chalasani;Herbert L. Bonkovsky;Robert Fontana;William Lee

  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

    Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie

  • Recommendations for the Diagnosis and Treatment of the Acute Porphyrias

    Karl E. Anderson;Joseph R. Bloomer;Herbert L. Bonkovsky;James P. Kushner

  • Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

    Anna S. Lok;Richard K. Sterling;James E. Everhart;Elizabeth C. Wright

  • Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

    Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C

    Timothy R. Morgan;Timothy R. Morgan;Marc G. Ghany;Hae Young Kim;Kristin K. Snow

  • Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct

    Robert J. Fontana;Paul B. Watkins;Herbert L. Bonkovsky;Naga Chalasani

  • Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

    Adrian M. Di Bisceglie;Mitchell L. Shiffman;Gregory T. Everson;Karen L. Lindsay

  • Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate

    Krishnan Venkataraman;Yong-Moon Lee;Jason Michaud;Shobha Thangada

  • High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C

    Bernard D. Clifford;Daniel Donahue;Lynda Smith;Edward Earl Cable

  • Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

    Herbert L Bonkovsky;Qaiser Jawaid;Kristina Tortorelli;Paula LeClair

  • Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

    Leonard B. Seeff;Gregory T. Everson;Timothy R. Morgan;Teresa M. Curto

  • Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

    Manisha Balwani;Eliane Sardh;Paolo Ventura;Paula Aguilera Peiró

  • Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial☆

    Adrian M. Di Bisceglie;Richard K. Sterling;Raymond T. Chung;James E. Everhart

  • Liver Injury From Herbals and Dietary Supplements in the U.S. Drug-Induced Liver Injury Network

    Victor J. Navarro;Huiman Barnhart;Herbert L. Bonkovsky;Timothy Davern

  • Iron and chronic viral hepatitis

    H L Bonkovsky;B F Banner;A L Rothman

  • Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

    N. Chalasani;H. L. Bonkovsky;R. Fontana;W. Lee

Frequent Co-Authors

Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Marc G. Ghany
Marc G. Ghany National Institutes of Health
Jules L. Dienstag
Jules L. Dienstag Harvard University
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University
Robert J. Fontana
Robert J. Fontana University of Michigan–Ann Arbor
Chihiro Morishima
Chihiro Morishima University of Washington
Gregory T. Everson
Gregory T. Everson University of Colorado Denver
Richard K. Sterling
Richard K. Sterling Virginia Commonwealth University
Anna S.F. Lok
Anna S.F. Lok University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens the door to a broad range of online degrees and health-related careers. For those interested in advanced clinical practice, consider exploring the cheapest dnp online programs. These Doctor of Nursing Practice degrees can be completed remotely and tend to be more budget-friendly than traditional options.

If pharmacy is your area of interest, accredited pharmd online programs offer flexibility for working professionals or those who cannot relocate. These programs focus on both clinical skills and pharmaceutical knowledge.

For students who prefer the administrative side of healthcare, earning a health information management degree online can prepare you for roles in managing patient records, medical data systems, and healthcare compliance.

Entry-level healthcare careers are also accessible online, such as medical coding and billing. Learn more about how much does it cost to become a medical coder and the variety of affordable online courses available for this in-demand field.

Exploring these online degree options can provide a flexible and affordable path into the healthcare industry beyond traditional medical school.

Best Scientists Citing Herbert L. Bonkovsky

Trending Scientists

Recently Published Articles